Today, we’re committing a portion of Anthropic’s shares to the Anthropic Public Benefit Fund,a new entity with a structure that increases the stake as the company grows. Subject to stockholder approval, 5% of Anthropic’s shares will be committed today, with an additional 2% added at the board’s discretion for every 50% increase in the company’s value above a set baseline.

As a public benefit corporation, most of our work in pursuit of our mission takes place inside the company: research relevant to AI safety and interpretability; applied biomedical research; discounts on Claude for nonprofits and scientific institutions. These activities have both a public benefit component and for-profit value, so we house them directly in the company.

The Anthropic Public Benefit Fund will have increased flexibility and scale, enabling us to pursue our mission in new ways: for example, we might explore large donations to traditional nonprofits or direct distributions to specific populations.